Search research articles
Contact Us
Filters
Showing results (971-980 of 1,011) with videos related to
Page
of 102
Sort By:
The Lancet. Oncology
|
December 8, 2018
Ibrutinib plus obinutuzumab versus chlorambucil plus obinutuzumab in first-line treatment of chronic lymphocytic leukaemia (iLLUMINATE): a multicentre, randomised, open-label, phase 3 trial
Carol Moreno, Richard Greil, Fatih Demirkan, et al.
Plos One
|
June 22, 2012
Inflammatory bowel diseases phenotype, C. difficile and NOD2 genotype are associated with shifts in human ileum associated microbial composition
Ellen Li, Christina M Hamm, Ajay S Gulati, et al.
American Journal of Hematology
|
February 16, 2019
Outcomes with ibrutinib by line of therapy and post-ibrutinib discontinuation in patients with chronic lymphocytic leukemia: Phase 3 analysis
Susan M O'Brien, John C Byrd, Peter Hillmen, et al.
Plos One
|
June 27, 2014
A GPBAR1 (TGR5) small molecule agonist shows specific inhibitory effects on myeloid cell activation in vitro and reduces experimental autoimmune encephalitis (EAE) in vivo
Nuruddeen D Lewis, Lori A Patnaude, Josephine Pelletier, et al.
Clinical Lymphoma, Myeloma & Leukemia
|
August 1, 2018
Safety Analysis of Four Randomized Controlled Studies of Ibrutinib in Patients With Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma or Mantle Cell Lymphoma
Susan O'Brien, Peter Hillmen, Steven Coutre, et al.
Physical Review Letters
|
June 4, 2011
Measurements of electron transport in foils irradiated with a picosecond time scale laser pulse
C R D Brown, D J Hoarty, S F James, et al.
Scientific Reports
|
July 1, 2025
Tracing chalcolithic population mobility using strontium isotopes and proteomics at Gumelnița site, Romania
Aurélien Tafani, Enrico Greco, Robert H Tykot, et al.
Blood Advances
|
June 15, 2019
Long-term safety of single-agent ibrutinib in patients with chronic lymphocytic leukemia in 3 pivotal studies
Steven E Coutre, John C Byrd, Peter Hillmen, et al.
Physical Review Letters
|
July 16, 2013
Observations of the effect of ionization-potential depression in hot dense plasma
D J Hoarty, P Allan, S F James, et al.
Journal of Extracellular Vesicles
|
June 24, 2023
First-in-human clinical trial of allogeneic, platelet-derived extracellular vesicles as a potential therapeutic for delayed wound healing
Jancy Johnson, Sam Q K Law, Mozhgan Shojaee, et al.
Page
of 102
Search research articles
Search
Showing results (971-980 of 1,011) with videos related to
Sort By:
Page
of 102
The Lancet. Oncology
|
December 8, 2018
Ibrutinib plus obinutuzumab versus chlorambucil plus obinutuzumab in first-line treatment of chronic lymphocytic leukaemia (iLLUMINATE): a multicentre, randomised, open-label, phase 3 trial
Carol Moreno, Richard Greil, Fatih Demirkan, et al.
Plos One
|
June 22, 2012
Inflammatory bowel diseases phenotype, C. difficile and NOD2 genotype are associated with shifts in human ileum associated microbial composition
Ellen Li, Christina M Hamm, Ajay S Gulati, et al.
American Journal of Hematology
|
February 16, 2019
Outcomes with ibrutinib by line of therapy and post-ibrutinib discontinuation in patients with chronic lymphocytic leukemia: Phase 3 analysis
Susan M O'Brien, John C Byrd, Peter Hillmen, et al.
Plos One
|
June 27, 2014
A GPBAR1 (TGR5) small molecule agonist shows specific inhibitory effects on myeloid cell activation in vitro and reduces experimental autoimmune encephalitis (EAE) in vivo
Nuruddeen D Lewis, Lori A Patnaude, Josephine Pelletier, et al.
Clinical Lymphoma, Myeloma & Leukemia
|
August 1, 2018
Safety Analysis of Four Randomized Controlled Studies of Ibrutinib in Patients With Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma or Mantle Cell Lymphoma
Susan O'Brien, Peter Hillmen, Steven Coutre, et al.
Physical Review Letters
|
June 4, 2011
Measurements of electron transport in foils irradiated with a picosecond time scale laser pulse
C R D Brown, D J Hoarty, S F James, et al.
Scientific Reports
|
July 1, 2025
Tracing chalcolithic population mobility using strontium isotopes and proteomics at Gumelnița site, Romania
Aurélien Tafani, Enrico Greco, Robert H Tykot, et al.
Blood Advances
|
June 15, 2019
Long-term safety of single-agent ibrutinib in patients with chronic lymphocytic leukemia in 3 pivotal studies
Steven E Coutre, John C Byrd, Peter Hillmen, et al.
Physical Review Letters
|
July 16, 2013
Observations of the effect of ionization-potential depression in hot dense plasma
D J Hoarty, P Allan, S F James, et al.
Journal of Extracellular Vesicles
|
June 24, 2023
First-in-human clinical trial of allogeneic, platelet-derived extracellular vesicles as a potential therapeutic for delayed wound healing
Jancy Johnson, Sam Q K Law, Mozhgan Shojaee, et al.
Page
of 102